Status:
UNKNOWN
Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions:
Ketoacidosis, Diabetic
Eligibility:
All Genders
12-35 years
Phase:
PHASE2
Brief Summary
This is a phase II trial in individuals who have been diagnosed with type 1 diabetes within the previous 12 months and suffered from diabetic ketoacidosis at onset of disease. The purpose of this stud...
Detailed Description
To assess the clinical efficacy of allogeneic umbilical cord mesenchymal stem cell transplantation in the treatment of patients with severe type 1 diabetes, defined as with the history of diabetic ket...
Eligibility Criteria
Inclusion
- Type 1 diabetes
- Duration of disease less than 12 months from diagnosis
- With the history of diabetic ketoacidosis
Exclusion
- Pregnancy
- Severe psychiatric disorder
- Severe organic impairment(renal,hepatic,cardiac,pulmonary)
- Active infectious disease
- Previous or present neoplastic disease
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02763423
Start Date
January 1 2009
End Date
December 1 2019
Last Update
May 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008